Health Care Trends: Payment Bundling--The Future of Reimbursement?
A number of industry experts have long believed that any significant change in health care must be tied to reimbursement, and the Centers for Medicare and Medicaid Services (CMS) has begun a pilot project that will test that theory. Under a three-year plan called the Acute Care Episode (ACE) demonstration, five sites in the US have been selected to use a single, bundled-payment system for hospital and physicians services associated with 28 cardiac and nine orthopedic inpatient surgical services and procedures.
by Robert Neil
As the movement to reform the US health system advances, it’s becoming clear that one of the simplest and longest held beliefs about running an efficient business is going to...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
The US FDA’s device center sent warning letters to three domestic device manufacturers and one German firm for failing to adhere to protocol on several issues.
Second submission window for joint scientific consultations on a procedure to help prepare for joint clinical assessments will open from 2 to 30 June 2025.
During MD&M East last week, regulatory consultant Darren Reeves reminded device manufacturers that the time to get ready to comply with the new Quality Management System Regulation is now.
Speakers at a recent UK medtech outlook conference voiced optimism about the sector’s prospects, but warned that cost burdens, over-regulation and lengthy processes will impede the capacity of local SMEs to innovate. Only 10% of NHS procured medtech comes from UK manufacturers.
Second submission window for joint scientific consultations on a procedure to help prepare for joint clinical assessments will open from 2 to 30 June 2025.
During MD&M East last week, regulatory consultant Darren Reeves reminded device manufacturers that the time to get ready to comply with the new Quality Management System Regulation is now.
Handheld diagnostics are more powerful, accessible and clinically relevant than ever. Medtech Insight spoke to companies behind such technologies to learn how they work and discuss their commercial models.
